ATE201822T1 - Verwendung von makroliden zur behandlung von zerebraler ischaemie - Google Patents
Verwendung von makroliden zur behandlung von zerebraler ischaemieInfo
- Publication number
- ATE201822T1 ATE201822T1 AT94903064T AT94903064T ATE201822T1 AT E201822 T1 ATE201822 T1 AT E201822T1 AT 94903064 T AT94903064 T AT 94903064T AT 94903064 T AT94903064 T AT 94903064T AT E201822 T1 ATE201822 T1 AT E201822T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- cerebral
- hemorrhage
- sec
- date
- Prior art date
Links
- 230000002490 cerebral effect Effects 0.000 title abstract 2
- 208000032109 Transient ischaemic attack Diseases 0.000 abstract 2
- 201000010875 transient cerebral ischemia Diseases 0.000 abstract 2
- 206010008088 Cerebral artery embolism Diseases 0.000 abstract 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 abstract 1
- 206010008132 Cerebral thrombosis Diseases 0.000 abstract 1
- 206010019196 Head injury Diseases 0.000 abstract 1
- 208000010496 Heart Arrest Diseases 0.000 abstract 1
- 208000032843 Hemorrhage Diseases 0.000 abstract 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 208000032851 Subarachnoid Hemorrhage Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 230000006931 brain damage Effects 0.000 abstract 1
- 231100000874 brain damage Toxicity 0.000 abstract 1
- 208000029028 brain injury Diseases 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 201000009939 hypertensive encephalopathy Diseases 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 208000020658 intracerebral hemorrhage Diseases 0.000 abstract 1
- 201000010849 intracranial embolism Diseases 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 208000023589 ischemic disease Diseases 0.000 abstract 1
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929227055A GB9227055D0 (en) | 1992-12-29 | 1992-12-29 | New use |
| PCT/JP1993/001886 WO1994014443A1 (en) | 1992-12-29 | 1993-12-24 | Use of macrolides for the treatment of cerebral ischemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE201822T1 true ATE201822T1 (de) | 2001-06-15 |
Family
ID=10727284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94903064T ATE201822T1 (de) | 1992-12-29 | 1993-12-24 | Verwendung von makroliden zur behandlung von zerebraler ischaemie |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5648351A (de) |
| EP (1) | EP0676961B1 (de) |
| JP (1) | JP3038920B2 (de) |
| KR (1) | KR100299856B1 (de) |
| CN (1) | CN1039622C (de) |
| AT (1) | ATE201822T1 (de) |
| AU (1) | AU687025B2 (de) |
| CA (1) | CA2152803A1 (de) |
| DE (1) | DE69330312T2 (de) |
| DK (1) | DK0676961T3 (de) |
| ES (1) | ES2157248T3 (de) |
| GB (1) | GB9227055D0 (de) |
| GR (1) | GR3036008T3 (de) |
| PT (1) | PT676961E (de) |
| TW (1) | TW291438B (de) |
| WO (1) | WO1994014443A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9206318D0 (en) * | 1992-03-24 | 1992-05-06 | Cambridge Antibody Tech | Binding substances |
| US6391899B1 (en) * | 1998-07-17 | 2002-05-21 | North Shore—Long Island Jewish Research Institute | Compounds and compositions for treating tissue ischemia |
| GB9917158D0 (en) * | 1999-07-21 | 1999-09-22 | Fujisawa Pharmaceutical Co | New use |
| WO2001024784A2 (en) * | 1999-10-04 | 2001-04-12 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| US20040147433A1 (en) * | 2001-06-14 | 2004-07-29 | Marcus Keep | Neuroimmunophilins for selective neuronal radioprotection |
| JP2004323414A (ja) * | 2003-04-24 | 2004-11-18 | Japan Science & Technology Agency | １４員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤 |
| JP2010515753A (ja) | 2007-01-10 | 2010-05-13 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | 肺内送達用免疫抑制剤組成物の送達の増強 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| WO1989005304A1 (en) * | 1987-12-09 | 1989-06-15 | Fisons Plc | Macrocyclic compounds |
| WO1991017754A1 (en) * | 1990-05-11 | 1991-11-28 | Fujisawa Pharmaceutical Co., Ltd. | Methods for treating and preventing inflammation of mucosa and blood vessels using fk 506 and related compounds |
| GB2248184A (en) * | 1990-09-28 | 1992-04-01 | Fujisawa Pharmaceutical Co | New use of macrolide compounds for active oxygen-mediated diseases |
| US5266594A (en) * | 1992-05-12 | 1993-11-30 | Dawson Valina L | Inhibitors of nitric oxide synthase and use thereof to prevent glutamate neurotoxicity |
-
1992
- 1992-12-29 GB GB929227055A patent/GB9227055D0/en active Pending
-
1993
- 1993-12-24 ES ES94903064T patent/ES2157248T3/es not_active Expired - Lifetime
- 1993-12-24 DE DE69330312T patent/DE69330312T2/de not_active Expired - Fee Related
- 1993-12-24 EP EP94903064A patent/EP0676961B1/de not_active Expired - Lifetime
- 1993-12-24 PT PT94903064T patent/PT676961E/pt unknown
- 1993-12-24 DK DK94903064T patent/DK0676961T3/da active
- 1993-12-24 US US08/464,815 patent/US5648351A/en not_active Expired - Fee Related
- 1993-12-24 JP JP06515010A patent/JP3038920B2/ja not_active Expired - Fee Related
- 1993-12-24 AU AU57160/94A patent/AU687025B2/en not_active Ceased
- 1993-12-24 AT AT94903064T patent/ATE201822T1/de not_active IP Right Cessation
- 1993-12-24 KR KR1019950702656A patent/KR100299856B1/ko not_active Expired - Fee Related
- 1993-12-24 CA CA002152803A patent/CA2152803A1/en not_active Abandoned
- 1993-12-24 WO PCT/JP1993/001886 patent/WO1994014443A1/en not_active Ceased
- 1993-12-27 TW TW082111036A patent/TW291438B/zh active
- 1993-12-29 CN CN93121752A patent/CN1039622C/zh not_active Expired - Fee Related
-
2001
- 2001-06-07 GR GR20010400743T patent/GR3036008T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1039622C (zh) | 1998-09-02 |
| TW291438B (de) | 1996-11-21 |
| CN1103580A (zh) | 1995-06-14 |
| EP0676961A1 (de) | 1995-10-18 |
| HK1012229A1 (en) | 1999-07-30 |
| CA2152803A1 (en) | 1994-07-07 |
| AU687025B2 (en) | 1998-02-19 |
| KR960700055A (ko) | 1996-01-19 |
| WO1994014443A1 (en) | 1994-07-07 |
| DE69330312T2 (de) | 2001-10-11 |
| PT676961E (pt) | 2001-10-30 |
| DK0676961T3 (da) | 2001-09-10 |
| EP0676961B1 (de) | 2001-06-06 |
| GR3036008T3 (en) | 2001-09-28 |
| ES2157248T3 (es) | 2001-08-16 |
| JP3038920B2 (ja) | 2000-05-08 |
| AU5716094A (en) | 1994-07-19 |
| GB9227055D0 (en) | 1993-02-24 |
| US5648351A (en) | 1997-07-15 |
| JPH08505136A (ja) | 1996-06-04 |
| KR100299856B1 (ko) | 2001-11-22 |
| DE69330312D1 (de) | 2001-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94037968A (ru) | Трициклические пирролпроизводные | |
| DE60226881D1 (de) | High-density -lipoprotein zur behandlung von schlaganfällen und ischämiezuständen | |
| RU94037964A (ru) | Производные 1-амино-этилиндола | |
| DE69213451D1 (de) | Fluoralkoxybenzylaminoderivate stickstoffhaltiger heterocyclen | |
| DE59409312D1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
| DK0581959T3 (da) | Anvendelse af makrolidforbindelser til øjensygdomme | |
| DE69317578D1 (de) | Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen | |
| ATE183389T1 (de) | Triphenylethylene zur vorbeugung und behandlung von osteoporose | |
| BR9407812A (pt) | Compostos uso e processo de preparação dos mesmos composições farmacêuticas uso das mesmas e processo de tratamento de ataques distúrbios neurológicos e/ou condições nas quais há dano neurológico nos animais incluindo seres humanos | |
| ATE224884T1 (de) | Muscarin-antagonisten | |
| FI964772A0 (fi) | (a)-annelloidut pyrrolijohdannaiset ja niiden käyttö farmasiassa | |
| ATE201822T1 (de) | Verwendung von makroliden zur behandlung von zerebraler ischaemie | |
| RU94037233A (ru) | Применение 2-фенил-3-ароилбензотиофенов для лечения лекарственноустойчивых новообразований | |
| DE69823851D1 (de) | Nefiracetam zur prophylaxe und behandlung von propofol verursachtem gedächtnisschwund | |
| DE69309297D1 (de) | Neuroprotektive 3,4-dihydro-2(1h)-chinolone | |
| DE69418689D1 (de) | Nitrone verwendbar zum abfangen von freien radikalen | |
| DE69400702D1 (de) | N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten | |
| DE69623767D1 (de) | Verwendung von pyrrolidinderivaten zur behandlung des alkoholismus | |
| ATE193206T1 (de) | Zusammensetzung zur behandlung oder vorbeugung von herpes | |
| DE69724944D1 (de) | Peptidverbindungen mit mmp- und tnf-hemmender wirkung | |
| DE69718925D1 (de) | Verfahren zur herstellung von n-[2-(dimethylamino)ethyl]akridin-4-carbonsäureamide | |
| ATE180478T1 (de) | Verwendung von substituierten 6-amino-4h-pyranen | |
| RU94044487A (ru) | Применение 2-фенил-3-ароилбензотиофенов для лечения мужского бесплодия | |
| ATE245199T1 (de) | Behandlung von influenzavirus-infektion unter verwendung von antiviralen acylierung/palmitylierung von hemagglutinin hemmen | |
| PT971714E (pt) | Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |